Evidence map›Paper›PMID 29226068›Full record

ArticleCurrent tropical medicine reports2016

Human Brucellosis and Adverse Pregnancy Outcomes.

Angela M Arenas-Gamboa, Carlos A Rossetti, Sankar P Chaki, Daniel G Garcia-Gonzalez, Leslie G Adams, Thomas A Ficht

Abstract read
In one paragraph

Article in Current tropical medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Glucose uptake is essential forInfection and immunity · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Septicemia caused bySAGE open medical case reports · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Human brucellosis in pregnancy - an overview.Bosnian journal of basic medical sciences · 2020
    Review
  17. Article
  18. Review
  19. Vaccine safety studies ofVaccine: X · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Angela M Arenas-GamboaDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Carlos A RossettiInstituto de Patobiología, CICVyA-CNIA, INTA, Nicolas Repetto y de Los Reseros s/n, Hurlingham, Buenos Aires, Argentina.
Sankar P ChakiDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Daniel G Garcia-GonzalezDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Leslie G AdamsDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Thomas A FichtDepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX 77843, USA.
Texas A&M University · USNational Institute of Industrial Technology · AR

Funding

Use of the goat model to test human Brucella vaccines in ArgentinaK01TW009981 · FIC · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ARENAS, ANGELA M · 2014 to 2018
$670k
FIC NIH HHS K01 TW009981
6 · The paper itself

Abstract

purpose of reviewBrucellosis is a neglected, zoonotic disease of nearly worldwide distribution. Despite brucellosis being recognized as a reproductive disease in animals, it has been historically known as a flu-like illness in humans with little or no significant role in maternal or newborn health. This review focuses on what is currently known relative to the epidemiology of brucellosis in human pregnancy as well as new insights of placental immunology. RECENT

findingsNew evidence suggests that maternal infection poses a significant risk factor for adverse pregnancy outcomes including increased risk for miscarriage during the first and second trimester of gestation, preterm delivery, and vertical transmission to the fetus. Adverse pregnancy outcomes were not associated with any specific clinical sign. However, prompt diagnosis and treatment significantly decreased the risk of miscarriage or any other adverse effect. SUMMARY: Brucellosis during pregnancy should be considered a significant risk factor for adverse pregnancy outcomes in humans. The identification of the mechanism behind bacterial tropism should prove powerful for the development of new countermeasures to prevent these detrimental effects. Increased awareness concerning brucellosis in pregnant women, its transmission, and prevention measures should be considered as a pressing need.

Indexed as

AbortionBrucellosisHumanPlacentaZoonosis

Identifiers

PMID29226068
PMCPMC5720386
OpenAlexW2531776619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.